ArticleNeurology and therapy2022

Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab.

Matthew Craner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.